EP2421517A4 - Controlled release dispensing device - Google Patents

Controlled release dispensing device

Info

Publication number
EP2421517A4
EP2421517A4 EP10767428.5A EP10767428A EP2421517A4 EP 2421517 A4 EP2421517 A4 EP 2421517A4 EP 10767428 A EP10767428 A EP 10767428A EP 2421517 A4 EP2421517 A4 EP 2421517A4
Authority
EP
European Patent Office
Prior art keywords
controlled release
dispensing device
release dispensing
controlled
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP10767428.5A
Other languages
German (de)
French (fr)
Other versions
EP2421517A2 (en
Inventor
Libin Barry
Jeffrey M Liebmann
Weiliam Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUSTAINED NANO SYSTEMS LLC
Original Assignee
SUSTAINED NANO SYSTEMS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/386,853 external-priority patent/US8071119B2/en
Priority claimed from US12/592,536 external-priority patent/US20100173000A1/en
Application filed by SUSTAINED NANO SYSTEMS LLC filed Critical SUSTAINED NANO SYSTEMS LLC
Publication of EP2421517A2 publication Critical patent/EP2421517A2/en
Publication of EP2421517A4 publication Critical patent/EP2421517A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
EP10767428.5A 2009-04-23 2010-04-21 Controlled release dispensing device Ceased EP2421517A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21445209P 2009-04-23 2009-04-23
US12/386,853 US8071119B2 (en) 2007-05-14 2009-04-23 Controlled release implantable dispensing device and method
US12/592,536 US20100173000A1 (en) 2007-05-14 2009-11-25 Controlled release implantable dispensing device and method
PCT/US2010/001191 WO2010123563A2 (en) 2009-04-23 2010-04-21 Controlled release dispensing device

Publications (2)

Publication Number Publication Date
EP2421517A2 EP2421517A2 (en) 2012-02-29
EP2421517A4 true EP2421517A4 (en) 2013-08-07

Family

ID=43011665

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10767428.5A Ceased EP2421517A4 (en) 2009-04-23 2010-04-21 Controlled release dispensing device

Country Status (4)

Country Link
EP (1) EP2421517A4 (en)
JP (2) JP2012524779A (en)
CA (1) CA2759807C (en)
WO (1) WO2010123563A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140322341A1 (en) * 2011-08-03 2014-10-30 Diane RUBIN Novel hemostatic patch and uses thereof
IL271908B2 (en) * 2017-07-11 2024-02-01 Sustained Nano Systems Llc Hypercompressed pharmaceutical formulations
CA3069155A1 (en) 2017-07-11 2019-01-17 Sustained Nano Systems Llc Radiation sterilization of hypercompressed polymer dosage forms
BR102020025389A2 (en) * 2020-12-11 2022-06-21 Edson Luiz Peracchi Long-term resorbable subcutaneous implant with sustained release of pre-concentrated, polymer-concentrated pharmacologically active substance for the treatment of nicotine addiction and process

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111603A1 (en) * 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5899411A (en) * 1981-12-05 1983-06-13 Shoichiro Ozaki Carcinostatic agent
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
CH679207A5 (en) * 1989-07-28 1992-01-15 Debiopharm Sa
FR2756493B1 (en) * 1996-12-02 2001-04-13 Delab DEVICE FOR LOCAL ADMINISTRATION OF SOLID OR SEMI-SOLID FORMULATIONS
WO1999048519A1 (en) * 1998-03-20 1999-09-30 Takeda Chemical Industries, Ltd. Sustained-release preparation of physiologically active polypeptide and production thereof
DE19856432A1 (en) * 1998-12-08 2000-06-15 Basf Ag Nanoparticulate core-shell systems and their use in pharmaceutical and cosmetic preparations
DE10224170A1 (en) * 2002-05-31 2003-12-11 Desitin Arzneimittel Gmbh Retarded release pharmaceutical composition, obtained without use of organic solvents or water by densifying mixture of active agent and retarding polymer in heated rollers
JP4475891B2 (en) * 2003-06-20 2010-06-09 ホソカワミクロン株式会社 Method for producing transpulmonary preparation
BRPI0514297A (en) * 2004-08-12 2008-06-10 Quest Pharmaceutical Services pharmaceutical compositions for controlled release of biologically active compounds
FR2880273B1 (en) * 2004-12-30 2007-03-30 Ceva Sante Animale Sa PROCESS FOR SEPARATING A SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE AND CONTROLLED AT HIGH PRESSURES
AU2008254989B2 (en) * 2007-05-14 2013-06-06 Sustained Nano Systems Llc Hypercompressed particles for controlled release of ophthalmic medications

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111603A1 (en) * 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process

Also Published As

Publication number Publication date
JP2016028066A (en) 2016-02-25
WO2010123563A3 (en) 2011-03-17
CA2759807A1 (en) 2010-10-28
WO2010123563A2 (en) 2010-10-28
JP2012524779A (en) 2012-10-18
EP2421517A2 (en) 2012-02-29
CA2759807C (en) 2018-03-20
JP6250005B2 (en) 2017-12-20

Similar Documents

Publication Publication Date Title
HK1203163A1 (en) Medicament dispensing device
EP2427379A4 (en) Dispensing apparatus
EP2412594A4 (en) Brake controlling device
EP2413443A4 (en) Ion-generation device
GB0909818D0 (en) Device
GB0905352D0 (en) Device
EP2441976A4 (en) Vibrationproof device
GB201014809D0 (en) Improved dispensing device
EP2409882A4 (en) Seatbelt device
EP2295987A4 (en) Dispensing device
ZA201105956B (en) Ejection device
EP2521148A4 (en) Electricity-storage device
ZA201105243B (en) Dispensing device
EP2421517A4 (en) Controlled release dispensing device
EP2476591A4 (en) Seatbelt device
GB0908083D0 (en) Anti-pecking device
GB2474673B (en) Dispensing device
GB2473070B (en) Dispensing apparatus
GB0917737D0 (en) Controlled dispenser
GB0909368D0 (en) Device
GB0900160D0 (en) Device
IL214193A0 (en) Doseg dispensing device
GB2469664B (en) Dispensing apparatus
IL216966A0 (en) Local therapeutic release device
GB0820080D0 (en) Dispensing device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20111028

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20130708

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101ALI20130702BHEP

Ipc: A61K 9/52 20060101AFI20130702BHEP

Ipc: A61K 9/51 20060101ALI20130702BHEP

Ipc: A61K 9/00 20060101ALI20130702BHEP

Ipc: A61K 9/50 20060101ALI20130702BHEP

Ipc: A61M 35/00 20060101ALI20130702BHEP

Ipc: A61K 9/16 20060101ALI20130702BHEP

Ipc: A61K 47/30 20060101ALI20130702BHEP

17Q First examination report despatched

Effective date: 20140325

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20190308